eli lilly oral semaglutide Orforglipron: Lilly's New GLP-1 Weight-loss Pill FDA approves Foundayo, an oral

The medication helps to physically slow the digestive process, keeping food in the body for longer periods, and reducing the appetite while promoting feelings of fullness through hormone mimicry

Appetite suppression often becomes more consistent as the medication is gradually increased to the full therapeutic dose

Then GLP-1 drugs produced weight loss that prior interventions rarely achieved, and we began to see obesity for what it is: a chronic disease, treatable with medication, not a failure of discipline

Interestingly, TG and apoB48 levels rapidly rise in the 2 h following the second meal in these patients to levels similar as pre-treatment responses (Schwartz et al., 2010)